Arlin Z - Search Results

1

Phase II study of mitoxantrone and 5-azacytidine for accelerated and blast crisis of chronic myelogenous leukemia: a study of the Eastern Cooperative Oncology Group.

Dutcher JP, Eudey L, Wiernik PH, Paietta E, Bennett JM, Arlin Z, Kellermeyer R, Rowe J, O'Connell M, Oken M, et al. Dutcher JP, et al. Among authors: arlin z. Leukemia. 1992 Aug;6(8):770-5. Leukemia. 1992. PMID: 1379312 Clinical Trial.

2

Blastic phase of chronic myeloid leukemia (blCML): a proposal for standardization of diagnostic and response criteria.

Arlin ZA, Silver RT, Bennett JM. Arlin ZA, et al. Leukemia. 1990 Nov;4(11):755-7. Leukemia. 1990. PMID: 2232887 Review.

3

Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.

Arlin Z, Case DC Jr, Moore J, Wiernik P, Feldman E, Saletan S, Desai P, Sia L, Cartwright K. Arlin Z, et al. Leukemia. 1990 Mar;4(3):177-83. Leukemia. 1990. PMID: 2179638 Clinical Trial.

4

A multicenter trial of cytarabine plus idarubicin or daunorubicin as induction therapy for adult nonlymphocytic leukemia.

Wiernik PH, Case DC Jr, Periman PO, Arlin ZA, Weitberg AB, Ritch PS, Todd MB. Wiernik PH, et al. Among authors: arlin za. Semin Oncol. 1989 Feb;16(1 Suppl 2):25-9. Semin Oncol. 1989. PMID: 2928807 Clinical Trial. No abstract available.

5

Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia.

Wiernik PH, Banks PL, Case DC Jr, Arlin ZA, Periman PO, Todd MB, Ritch PS, Enck RE, Weitberg AB. Wiernik PH, et al. Among authors: arlin za. Blood. 1992 Jan 15;79(2):313-9. Blood. 1992. PMID: 1730080 Free article. Clinical Trial.

6

The location of breakpoints within the breakpoint cluster region (bcr) of chromosome 22 in chronic myeloid leukemia.

Eisenberg A, Silver R, Soper L, Arlin Z, Coleman M, Bernhardt B, Benn P. Eisenberg A, et al. Among authors: arlin z. Leukemia. 1988 Oct;2(10):642-7. Leukemia. 1988. PMID: 3172841

7

Homoharringtonine is safe and effective for patients with acute myelogenous leukemia.

Feldman E, Arlin Z, Ahmed T, Mittelman A, Puccio C, Chun H, Cook P, Baskind P. Feldman E, et al. Among authors: arlin z. Leukemia. 1992 Nov;6(11):1185-8. Leukemia. 1992. PMID: 1434802 Clinical Trial.

8

Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol.

Berman E, Arlin ZA, Gaynor J, Miller W, Gee T, Kempin SJ, Mertelsmann R, Andreeff M, Reich L, Nahmias N, et al. Berman E, et al. Among authors: arlin za. Leukemia. 1989 Feb;3(2):115-21. Leukemia. 1989. PMID: 2911205 Clinical Trial.

9

Homoharringtonine in combination with cytarabine for patients with acute myelogenous leukemia.

Feldman E, Arlin Z, Ahmed T, Mittelman A, Puccio C, Chun H, Cook P, Baskind P. Feldman E, et al. Among authors: arlin z. Leukemia. 1992 Nov;6(11):1189-91. Leukemia. 1992. PMID: 1434803 Clinical Trial.

10

Short course high dose mitoxantrone with high dose cytarabine is effective therapy for adult lymphoblastic leukemia.

Arlin ZA, Feldman EJ, Finger LR, Ahmed T, Mittelman A, Cook P, Puccio C, Baskind P, Arnold P, Razis ED, et al. Arlin ZA, et al. Leukemia. 1991 Aug;5(8):712-4. Leukemia. 1991. PMID: 1886423

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters